Active Ingredient History
Epigallocatechin gallate (EGCG), also known as epigallocatechin-3-gallate, is the ester of epigallocatechin and gallic acid, and is a type of catechin. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Affect (Phase 4)
Alzheimer Disease (Phase 2/Phase 3)
Amyloidosis (Phase 2)
Angina, Stable (Phase 2)
Antioxidants ()
Arthritis, Rheumatoid (Phase 3)
Autoimmune Diseases (Phase 2)
Brain Injuries, Traumatic (Phase 2/Phase 3)
Breast Neoplasms (Phase 2)
Carcinoma, Squamous Cell (Phase 3)
Cardiovascular Diseases (Phase 2)
Cognition (Phase 4)
Colorectal Neoplasms (Phase 2)
COVID-19 (Phase 2/Phase 3)
Dermatitis (Phase 2)
Diabetes Mellitus (Phase 2/Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Diabetic Nephropathies (Phase 2)
Diabetic Retinopathy (Phase 1)
Down Syndrome (Phase 2)
Drugs, Investigational (Phase 3)
Endometriosis (Phase 2)
Esophagitis (Phase 2)
Fetal Alcohol Spectrum Disorders (Phase 2/Phase 3)
Frailty (Phase 2)
Glaucoma, Open-Angle (Phase 1/Phase 2)
Head and Neck Neoplasms (Phase 1)
Heart Diseases (Phase 2)
Hepatitis C (Phase 3)
Hepatitis C, Chronic (Phase 1)
Huntington Disease (Phase 2)
Hypercholesterolemia (Phase 2)
Hyperlipidemias (Phase 3)
Hypertension (Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 1/Phase 2)
Inflammation (Phase 2)
Inositol (Phase 3)
Insulin Resistance (Phase 2)
Leiomyoma (Phase 3)
Lichen Planus, Oral (Phase 3)
Liver Cirrhosis (Phase 2)
Lung Diseases, Interstitial (Phase 1/Phase 2)
Lung Neoplasms (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Metabolism (Phase 4)
Mucositis (Phase 1/Phase 2)
Multiple Sclerosis (Phase 2/Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 1/Phase 2)
Multiple System Atrophy (Phase 3)
Muscular Dystrophy, Duchenne (Phase 2/Phase 3)
Nasopharyngeal Carcinoma (Phase 2/Phase 3)
Neoplasms (Phase 1/Phase 2)
Obesity (Phase 3)
Ocular Hypertension (Phase 1/Phase 2)
Osteoporosis (Phase 1/Phase 2)
Oxidative Stress (Phase 1)
Parkinson Disease (Phase 2)
Prostatic Neoplasms (Phase 2/Phase 3)
Radiodermatitis (Phase 1/Phase 2)
Small Cell Lung Carcinoma (Phase 1)
Triple Negative Breast Neoplasms (Early Phase 1)
Tuberculosis (Phase 1)
Vitamin B 6 (Phase 3)
Vitamin D (Phase 3)
Weight Loss (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue